Evidence map›Paper›PMID 23217714›Full record

ArticleCell2012

Norrin/Frizzled4 signaling in retinal vascular development and blood brain barrier plasticity.

Yanshu Wang, Amir Rattner, Yulian Zhou, John Williams, Philip M Smallwood, Jeremy Nathans

Open access · bronzeAbstract read
In one paragraph

Article in Cell, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 264 papers.

0numbers the graph read from it
0cells of the map it votes in
264citing papers in PubMed
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

264 citing papers in PubMed, 389 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

204 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Yanshu WangDepartment of Molecular Biology and Genetics, Howard Hughes Medical Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Amir Rattner
Yulian Zhou
John Williams
Philip M Smallwood
Jeremy Nathans
Johns Hopkins University · USJohns Hopkins Medicine · USHoward Hughes Medical Institute · US

Funding

The control of retinal vascular development by Norrin and Frizzled4R01EY018637 · NEI · JOHNS HOPKINS UNIVERSITY · PI NATHANS, JEREMY · 2008 to 2021
$5.5M
Howard Hughes Medical InstituteNEI NIH HHS R01 EY018637
6 · The paper itself

Abstract

Norrin/Frizzled4 (Fz4) signaling activates the canonical Wnt pathway to control retinal vascular development. Using genetically engineered mice, we show that precocious Norrin production leads to premature retinal vascular invasion and delayed Norrin production leads to characteristic defects in intraretinal vascular architecture. In genetic mosaics, wild-type endothelial cells (ECs) instruct neighboring Fz4(-/-) ECs to produce an architecturally normal mosaic vasculature, a cell nonautonomous effect. However, over the ensuing weeks, Fz4(-/-) ECs are selectively eliminated from the mosaic vasculature, implying the existence of a quality control program that targets defective ECs. In the adult retina and cerebellum, gain or loss of Norrin/Fz4 signaling results in a cell-autonomous gain or loss, respectively, of blood retina barrier and blood brain barrier function, indicating an ongoing requirement for Frizzled signaling in barrier maintenance and substantial plasticity in mature CNS vascular structure.

Indexed as

Blood-Brain BarrierBlood-Retinal BarrierSignal TransductionAnimalsCell MovementCell ProliferationEndothelial CellsEye ProteinsFrizzled ReceptorsHumansMiceMosaicismNerve Tissue ProteinsNeuronal PlasticityRetinaVascular Endothelial Growth Factor AEye ProteinsFrizzled ReceptorsFzd4 protein, mouseNdph protein, mouseNerve Tissue ProteinsVascular Endothelial Growth Factor AVEGFA protein, human

Identifiers

PMID23217714
PMCPMC3535266
OpenAlexW2017912617

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.